The agreement encompasses development and commercial milestones for the products, which could amount to up to $180m.

The IgA Nephropathy drugs market is set for 18.1% CAGR growth, led by biologics, FDA approvals, and major pharma R&D efforts ...

The government is expected to launch a new inquiry into the pricing and reimbursement system of pharmaceuticals in Sweden, ...

Industry stakeholders have urged the European Medicines Agency to sharpen its guidance on decentralized clinical trials, ...

Platinum is showing the least volatility of the three metals. Price continues to oscillate within a tight symmetrical triangle, bounded by support at $1,058 and resistance at $1,100. Volatility has ...

Explore the evolving landscape of cell and gene therapies (CGTs) in gastroenterology. Key therapies include Anterogen's Cupistem and Takeda's Alofisel, the latter recently withdrawn by EMA. Understand ...

The global ATMPs Consulting Market is expected to witness a healthy and a double-digit growth rate by 2027. The key factors ...

Anal cancer is relatively uncommon, accounting for approximately 2.5% of all gastrointestinal cancers. Nonetheless, its ...

(Alliance News) - Nuformix PLC on Thursday said its lead programme, NXP002, has been granted orphan drug designation by the European Medicines Agency for the treatment of idiopathic pulmonary fibrosis ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

Detecting tryptophan and other metabolites can be done using various techniques. Researchers created a new UHPLC–MS/MS-based ...